Crescita Therapeutics Inc. (TSE:CTX – Get Free Report) was down 2.1% during mid-day trading on Thursday . The company traded as low as C$0.47 and last traded at C$0.47. Approximately 4,000 shares changed hands during trading, a decline of 89% from the average daily volume of 35,187 shares. The stock had previously closed at C$0.48.
Crescita Therapeutics Stock Performance
The company has a quick ratio of 2.29, a current ratio of 3.12 and a debt-to-equity ratio of 2.98. The company’s 50-day moving average is C$0.48 and its 200 day moving average is C$0.47. The company has a market cap of C$8.66 million, a price-to-earnings ratio of 23.25 and a beta of -0.39.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.
Featured Articles
- Five stocks we like better than Crescita Therapeutics
- Elon Musk’s $1 Quadrillion AI IPO
- Silver paying 20% dividend. Plus 68% share gains
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Look who’s buying 2 tonnes of gold… per week!
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
